-
Signature
-
/s/ Allison Blais, as attorney-in-fact
-
Issuer symbol
-
ADBE
-
Transactions as of
-
15 Dec 2023
-
Net transactions value
-
-$305,906
-
Form type
-
4
-
Filing time
-
19 Dec 2023, 18:02:21 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ADBE |
Common Stock |
Options Exercise |
$0 |
+62 |
+1.5% |
$0.000000 |
4,117 |
15 Dec 2023 |
Direct |
|
| transaction |
ADBE |
Common Stock |
Tax liability |
$17,540 |
-30 |
-0.73% |
$584.68 |
4,087 |
15 Dec 2023 |
Direct |
F1 |
| transaction |
ADBE |
Common Stock |
Options Exercise |
$0 |
+458 |
+11% |
$0.000000 |
4,545 |
15 Dec 2023 |
Direct |
|
| transaction |
ADBE |
Common Stock |
Tax liability |
$132,722 |
-227 |
-5% |
$584.68 |
4,318 |
15 Dec 2023 |
Direct |
F1 |
| transaction |
ADBE |
Common Stock |
Sale |
$155,643 |
-263 |
-6.1% |
$591.80 |
4,055 |
18 Dec 2023 |
Direct |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ADBE |
Restricted Stock Units |
Options Exercise |
$0 |
-458 |
-17% |
$0.000000 |
2,292 |
15 Dec 2023 |
Common Stock |
458 |
$0.000000 |
Direct |
F3 |
| transaction |
ADBE |
Restricted Stock Units |
Options Exercise |
$0 |
-62 |
-17% |
$0.000000 |
310 |
15 Dec 2023 |
Common Stock |
62 |
$0.000000 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: